Daicel Life Sciences provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver biologicals, including Nucleic acids, without the use of needles, LNPs or other carriers. Delivery can be SC, ID, or IM. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method. | Daicel Life Sciences provides products and services to a wide array of the Pharmaceutical market. In the area of drug delivery, our Actranza lab. device is designed to inject biological drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, this unique needle-free injector has been proven to deliver mRNA and DNA into the cell and achieve production of the desired protein or antibody. | Daicel is a diversified technology company with unique capabilities that are being applied to a wide variety of applications, including Medical-grade plastics, Life-saving air bags, Engineered plastics, and the products of our Life Science SBU. Daicel’s Life Sciences SBU provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver RNA and DNA vaccines intracellularly without the use of needles, LNPs or other carriers. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.
Cytiva
With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical expertise and talent, a broad and deep portfolio, and exceptional service help researchers and biopharma advance therapeutics at every stage from discovery to delivery. We supply the tools and support our customers need to work better, faster, and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. Visit cytiva.com to learn more. | Diagnostic assays like the ones you’re developing are in demand. Set yourself up for success by choosing a supplier that delivers quality products for your entire workflow and offers specialized services and capabilities needed to commercialize your assays. Using a single supplier for multiple components, from membranes to magnetic beads, can streamline your development process and ultimately accelerate the commercialization of diagnostic assays and kits. Cytiva can help you speed up and scale up without staffing up! With a rich heritage dating back hundreds of years, Cytiva brings a wealth of technical knowledge and talent, a broad and deep portfolio, and exceptional service to support biotechs at every stage from discovery to delivery. Visit cytiva.com/diagnostics to learn more. | Cytiva and Pall Life Sciences have come together to deliver the breadth, depth, and scale researchers and biopharma need to advance future therapeutics – from discovery to delivery. Together, as Cytiva, we supply the tools and support our customers need to work better, faster and safer, leading to the delivery of transformative medicines to patients. Our combined portfolio includes well-recognized names such as Allegro™, Supor™, iCELLis™, and Kleenpak™, in addition to ÄKTA™, Amersham™, Biacore™, FlexFactory™, HyClone™, MabSelect™, Sefia™, Whatman™, and Xcellerex™. | Cytiva is a global life sciences leader that works with academic and translational researchers, developers and manufacturers of biotherapeutics, cell and gene therapies, and new technologies such as mRNA, to enable the delivery of transformative medicines. Cytiva is a trusted expert with nearly 10 000 associates in 43 countries dedicated to customers’ speed, flexibility, capacity and efficiency in drug discovery, research, and manufacturing.
Cytosurge AG
Cytosurge is a biotechnology company that provides the world’s only technology that allows scientists to physically access, perturb, and profile the same living cell over time, enabling insights that snapshot methods cannot capture > FluidFM combines microfluidics and force microscopy to enable gentle interactions with cells; based on this unique technology, we empower scientists to read, write, and analyze life as it unfolds. Experience the revolution of Same-Cell Biology with FluidFM OMNIUM. The single-cell biopsy solution on the FluidFM OMNIUM platform provides a unique workflow for extraction of a part of the cytoplasm from individual living cells while preserving their viability. These cytoplasmic biopsies can be used for subsequent highly sensitive, low-input RNA-seq analysis to characterize single-cells multiple times throughout their lifetime. This enables temporal profiling to track how baseline states and treatments causally drive future behavior, delivering data that reveals mechanisms rather than just correlations. CellEDIT service: Vector-free, controlled genome engineering. Empowered by FluidFM, CellEDIT delivers precise doses without vectors, multiplex edits even in hard-to-transfect cells—without viral toxicity or electroporation. We provide unprecedented control to generate clean, reproducible, and physiologically relevant models. Finally obtain the edits you need, reliably. You name the edit, we edit it. BOOTH #617.
Cyanagen srl
Cyanagen Srl is an Italian biotech company founded in Bologna in 2003. The Company’s core business is designing, developing and manufacturing reagents for life sciences (RUO) and In Vitro Diagnostics (IVD). Mainly chemiluminescent substrates, fluorescent antibodies, magnetic beads, and DNA/RNA extraction kits. Our key technologies, covered by international patents, achieve outstanding sensitivity, stability, performance and ease of use. Thanks also to the OEM sales to global companies, Cyanagen is one of the world’s leading manufacturers of chemiluminescent substrates for Western blotting and ELISA/CLIA. Cyanagen also manufactures custom products according to clients’ specifications and starting materials in bulk sizes. Thanks to its experience IVD manufacturing, Cyanagen offers support in Analytical Validation Processes and for developing molecular diagnostics & biological assays. Cyanagen actively partners with EU universities and other companies for national and international calls. Certifications: ISO9001:2015 – ISO13485:2016.
CUSABIO TECHNOLOGY LLC
CUSABIO Technology is a National High-Tech Enterprise with research, production, and sales in one. After 18 years of effort, CUSABIO has become a good partner to researchers worldwide. We are dedicated to providing 67,000+ validated antibodies, 12,000+ recombinant proteins, 660+ cytokines, and thousands of ELISA kits to global customers in the research fields of cancer, cell biology, immunology, neuroscience, epigenetics, etc. Our products can meet customers’ different demands in various scientific research fields.
Curiosis
Curiosis Inc. is dedicated to developing, producing, and supplying innovative systems for cell-based analysis and lab automation. Our advanced solutions are designed to enhance the efficiency, precision, and scalability of cell-based research, helping scientists and medical professionals achieve better outcomes. We strive to establish ourselves as a leader in the bioindustry, focusing on delivering products that meet the evolving needs of both scientific and medical communities. By integrating cutting-edge technologies and fostering continuous innovation, we aim to make significant contributions to the advancement of biomedical research and the improvement of global healthcare outcomes.
CTCELLS
CTCELLS is an innovative cancer diagnostics and drug development company founded on the belief that effective cancer care requires solutions tailored to each individual. Powered by Circulating Tumor Cell (CTC) liquid biopsy, CTCELLS enables automated isolation of diverse CTC subtypes to better capture the full biological heterogeneity of cancer. To translate these insights into actionable research and clinical value, CTCELLS integrates its proprietary Continuous Centrifugal Microfluidics (CCM) technology for robust, automated CTC processing, lossless cell staining enabled by hydrogel-based HypICC to preserve cellular information for downstream analysis, and single-cell picking to support precise molecular profiling and functional characterization. By connecting cancer-specific cellular characteristics with the most suitable therapies, CTCELLS is committed to improving patient outcomes and accelerating the development of next-generation treatments, bringing new hope to patients facing difficult-to-treat cancers. | CTCELLS is an innovative biotechnology company striving for a total solution for cancer. With platform technologies in both therapeutics and diagnostics, the RACE platform is designed to deliver safer and more effective immunotherapies by optimizing the selection and administration of treatment based on a patient’s unique immunological profile. The TRACE Platform, on the other hand, is a cutting-edge liquid biopsy system that captures all types of Circulating Tumor Cells (CTCs). This allows for more precise diagnostics and treatment planning, targeting a range of cancer types. CTCELLS is committed to improving patient outcomes by integrating the latest in scientific research and technology into their products.
Crown Bioscience
Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) dedicated to advancing human health by partnering with biotech and pharmaceutical companies that drive drug discovery and development in oncology and immuno-oncology. We provide a range of integrated solutions, which include preclinical research services, translational platforms, and clinical trial support. Our offer includes the world’s largest commercially available patient-derived xenograft (PDX) collection and over 600 tumor organoid models using Hubrecht Organoid Technology, covering 22 cancer indications. Our expertise extends across a diverse portfolio of platforms and services that utilize in vivo, in vitro, ex vivo, and in silico methods, along with advanced laboratory services that span the entire drug development timeline. Additionally, we maintain an extensive biobank of liquid and human biospecimens, complete with clinical histories. Operating from 11 facilities in the US, Europe, and APAC—including laboratories accredited by the College of American Pathologists (CAP) and the International Organization for Standardization (ISO)—we ensure the highest standards of quality and reliability in our research environments. For more information, please visit www.crownbio.com. | Crown Bioscience, a JSR Life Sciences company, is a global contract research organization (CRO) providing discovery, preclinical and translational platforms to advance oncology, immuno-oncology, and immune-mediated inflammatory diseases. Known for their high quality and expansive in vivo, in vitro and ex vivo preclinical models, they partner with their clients to quantify the efficacy and pharmacological profile of their drug candidate before they move into the clinic. The company is the only preclinical CRO to provide tumor organoid services utilizing HUB technology and has the world’s largest commercially available PDX collection. Additionally, further services available in the areas of high content imaging and a 3D Ex Vivo Patient Tissue Platform, provide greater insights into complex disease pathophysiology. A range of biomarker analysis and applied genomics services are also available to optimize therapeutic benefit. Crown Bioscience helps to deliver superior drug candidates to ensure that patients get the right treatment at the right time. Founded in 2006, Crown Bioscience has nine facilities in the US, Europe, and Asia. Find out more: www.crownbio.com
Creative Biomart Inc
Creative BioMart is a leading biotech company that provides innovative products and services to the scientific community worldwide. We specialize in developing and manufacturing high-quality recombinant proteins, and custom services for life science research, drug discovery, and diagnostic applications. We pride ourselves on our customer-centric approach, which ensures our customers receive exceptional service and support at every stage of their research project. Whether you need any help, our team is always available to help.
Covaris
Covaris, a PerkinElmer Company, is a leader in sample preparation solutions across multiomics research and clinical applications. Powered by proprietary Adaptive Focused Acoustics® (AFA®) technology, our portfolio of advanced instruments, consumables, reagents, and kits for pre-analytical sample preparation deliver exceptional accuracy and reproducibility, enabling researchers to generate higher-quality data, develop novel assays, and drive breakthrough discoveries in life sciences. From academic labs to global biopharma organizations, Covaris is trusted by scientists who demand precision at every step of the analytical workflow. Learn more at www.covaris.com. | Covaris provides comprehensive, integrated workflows for proteomics, genomics, and beyond. Covaris solutions can help you improve your sample preparation performance. They easily integrate into manual or automated workflows and support a wide variety of sample types, batch sizes, and input volumes. By reducing touchpoints, turnaround time, and repeat downstream analysis, Covaris sample prep solutions can lower your total workflow costs. Learn how Covaris can help take you further, faster.